Pharmacological Therapy for Management of Stage C HFrEF
{"Image DocumentName": "Pharmacological Therapy for Management of Stage C HFrEF", "Image ImageDescription": "Recommendations. COR. LOE. Diuretics. Diuretics are recommended in patients with HFrEF with fluid retention. I. C. ACE Inhibitors. ACE inhibitors are recommended for all patients with HFrEF. A. ARBs. ARBs are recommended in patients with HFrEF who are ACE inhibitor intolerant. ARBs are reasonable as alternatives to ACE inhibitor as first line therapy in HFrEF. IIa. The addition of an ARB may be considered in persistently symptomatic patients with HFrEF on GDMT. IIb. Routine combined use of an ACE inhibitor, ARB, and aldosterone antagonist is potentially harmful. III: Harm slide 37.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}